Evaluation of combined therapy in carcinoma of the bladder.
A number of studies are considered in order to evaluate the benefits of combined treatment for patients with Stage B2C transitional carcinoma of the bladder. It is found that for a variety of reasons, such treatment is not shown to be beneficial; the conclusion is that routine combined preoperative therapy is investigative but cannot be recommended as a community standard.
D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy*